VARANASI, July 8 -- The Banaras Hindu University on Monday signed an MoU with M/s EUPRIS Biologicals Pvt. Ltd, transferring the licensing rights of a patent, received for the preparation of Curcumin Quantum Dots, for its commercialization. EUPRIS Biologicals is a Private limited firm that is a highly efficient and innovation-driven manufacturing enterprise, equipped with facilities and skilled technical team capable of scaling and producing complex formulations with precision. The MoU was signed by Prof Arun Kumar Singh, registrar, and Abhishek Singh, project coordinator, EUPRIS Biologicals, in the presence of Rector and officiating vice-chancellor Prof Sanjay Kumar. Himanshu Agrawal, chief financial officer (CFO), EUPRIS Biologicals, received the agreement. Prof Sanjay Kumar congratulated the BHU team for achieving this milestone in technology transfer. He lauded the efforts of IPRTT Task Force and the hard work of the research team for both their innovation and for realising the idea of commercializing research for the greater good. The innovation, duly patented by the Government of India, has been carried out by Prof Pradyot Prakash (Department of Microbiology, Institute of Medical Sciences), Prof Monika Bansal (Faculty of Dental Sciences, Institute of Medical Sciences), Prof Rakesh Kumar Singh (Department of Biochemistry, Institute of Science) and Dr Ashish Kumar Singh (Department of Biochemistry, Patna University, and former Research Associate at BHU). This cutting-edge technology of preparing Curcumin Quantum Dots (CurQDs) marks a significant milestone in the commercial production of products containing CurQDs. Derived from curcumin, a natural compound found in turmeric, CurQDs combine nanoscale precision with potent antibacterial, antibiofilm, antioxidant, and anti-inflammatory properties. The patented method ensures biocompatible production, overcoming traditional limitations of curcumin, such as poor solubility and bioavailability. In cosmetics, CurQDs offer unparalleled potential for advanced skincare solutions. Their ability to penetrate biofilms and combat bacteria makes them ideal for anti-acne treatments, while their antioxidant properties protect against UV-induced aging and promote skin repair. In pharmaceuticals, CurQDs ability to disrupt bacterial biofilms and inhibit virulence factors opens new avenues for treating chronic infections, such as periodontitis....